SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-040242
Filing Date
2024-04-02
Accepted
2024-04-02 16:33:49
Documents
16
Period of Report
2024-03-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A crbp-20240329.htm   iXBRL DEF 14A 1194151
2 GRAPHIC img115876698_0.jpg GRAPHIC 27175
3 GRAPHIC img115876698_1.jpg GRAPHIC 23317
4 GRAPHIC img115876698_2.jpg GRAPHIC 47912
5 GRAPHIC img115876698_3.jpg GRAPHIC 55614
  Complete submission text file 0000950170-24-040242.txt   2429480

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20240329.xsd EX-101.SCH 26567
19 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20240329_htm.xml XML 291970
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37348 | Film No.: 24814853
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)